ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >(3R,4R)-N,4-dimethyl-piperidin-3-amine

(3R,4R)-N,4-dimethyl-piperidin-3-amine

Request For Quotation
(3R,4R)-N,4-dimethyl-piperidin-3-amine Suppliers list
Company Name: Quality Control Solutions Ltd.  
Tel: 0755-66853366 13670046396
Email: orders@qcsrm.com
Company Name: Shandong Boluoda Biological Technology Co., Ltd.  
Tel: 0531-68651502
Email: 2310993908@qq.com
Company Name: Shanghai Changyan Chem & Tech Co., Ltd.  
Tel: 021-20242659 18930833303
Email: sales@changyanchem.cn
Company Name: Hubei Yangxin Medical Technology Co., Ltd.  
Tel: 15374522761
Email: 3003392093@yongstandards.com
Company Name: Shanghai Han-Xiang Chemical Co., Ltd.  
Tel: 17754423994
Email: candy@biochempartner.com
(3R,4R)-N,4-dimethyl-piperidin-3-amine Basic information
Product Name:(3R,4R)-N,4-dimethyl-piperidin-3-amine
Synonyms:(3R,4R)-N,4-dimethyl-piperidin-3-amine;Tofacitinib Related Impurity 1;(3R,4R)-3-methylamino-4-methyl-piperidine;3-Piperidinamine, N,4-dimethyl-, (3R,4R)-;Pethidine Impurity 13;(3R,4R)-N,4-dimethylpiperidin-3-amine? (Tofacitinib Impurity）;Tofatinib Impurity 13;(3R,4R)-N,4-Dimethyl-3-piperidinamine
CAS:1354469-76-3
MF:C7H16N2
MW:128.22
EINECS:
Product Categories:
Mol File:1354469-76-3.mol
(3R,4R)-N,4-dimethyl-piperidin-3-amine Structure
(3R,4R)-N,4-dimethyl-piperidin-3-amine Chemical Properties
storage temp. Store at 0-8 °C
Safety Information
MSDS Information
(3R,4R)-N,4-dimethyl-piperidin-3-amine Usage And Synthesis
Uses(3R,4R)-N,4-Dimethyl-piperidin-3-amine is an intermediate in the preparation of the drug Tofacitinib.
(3R,4R)-N,4-dimethyl-piperidin-3-amine Preparation Products And Raw materials
Tag:(3R,4R)-N,4-dimethyl-piperidin-3-amine(1354469-76-3) Related Product Information
tert-butyl N-[(3R,5S)-5-methylpiperidin-3-yl]carbamate (3R,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine methyl3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin -4-yl)amino)piperidin-1-yl)-3-oxopropanoate Ethyl S-4-chloro-3-hydroxybutyrate 2-amino-4-fluoro-5-nitrobenzoic acid 4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine (3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile (S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine Tofacitinib Impurity 20 R-afatinib 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile Tofacitinib Impurity 19 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine